All posts

Is Schwazze a buy? (August, 2024)

Following the company’s second quarter results, Beacon analyst Russell Stanley has maintained his “Buy” rating on Schwazze (Schwazze Stock Quote, Chart, News, Analysts, Financials NEO:SHWZ).

On August 13, SHWZ reported its Q2, 2024 results. The company posted Adjusted EBITDA of $9.03-million on revenue of $43.3-million.

“We made solid progress on our growth and optimization initiatives in Q2 and generated sequential quarterly growth across all key financial metrics while advancing our retail strategy,” interim CEO Forrest Hoffmaster said. “During the quarter, we continued to deepen our customer understanding, sharpen our pricing and promotional strategy, enhance the in-store experience, and improve our assortment and in-stock positions. These efforts drove increased store traffic and market share expansion in both Colorado and New Mexico. In our wholesale business, we generated our second consecutive period of quarter-over-quarter growth in both states with penetration growth and catalog expansion while improving wholesale margins.”

The analyst summarized the quarter.

“SHWZ recently reported Q2 revenue/adjusted EBITDA of $43.2M/$9.0M v. our forecast of $42.4M/$8.4M and consensus at $41M/$8.5M,” he wrote. “Revenue improved 2% y/y primarily through new store additions, offset by continued price pressure in both CO and NM. SHWZ has delivered strong wholesale penetration in both markets, increasing its CO penetration from 21% to 34%, and its NM penetration from 19% to 35% during H1. Gross margins were 115 bps below forecast, but still improved 94 bps q/q. The y/y decline of almost 1,400 bps can be attributed primarily to price pressure and secondarily to revenue mix (more reliance on 3rd party products in NM, and an increase in medical’s share of revenue v. adult-use in CO). Better/lower-than-expected OPEX more than offset the gross margin shortfall v. our forecast, resulting in adjusted EBITDA margins that beat our forecast by 115 bps, improving 232 bps q/q. Operating cash flow was negative $3M before working capital, missing our forecast of +$2M, although the company broke even net of working capital changes.”

In a research update to clients August 16, Stanley maintained his “Buy” rating and price target of $2.00 on SHWZ, implying a return of 545% at the time of publication.

The analyst thinks the company will post Adjusted EBITDA of$37.0-million on revenue of $171.0-million in fiscal 2024. He expects those numbers will improve to Adjusted EBITDA of Z$58.0-million on revenue of $188.0-million in fiscal 2025.

Tagged with: shwz
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Air Canada stock upgraded at RBC, target raised to $25.00

Following the company's most recent results, RBC Dominion Securities analyst James McGarragle is feeling more bullish about Air Canada (Air… [Read More]

8 hours ago

Docebo downgraded at ATB Capital

Docebo (Docebo Stock Quote, Chart, News, Analysts, Financials TSX:DCBO) is under scrutiny following its Q1 2025 earnings report. Despite reporting… [Read More]

9 hours ago

Verano Holdings is undervalued, Haywood says

Haywood Capital Markets analyst Neal Gilmer says Verano Holdings (Verano Holdings Stock Quote, Chart, News, Analysts, Financials NEO:VRNO) is staying… [Read More]

3 days ago

Knight Therapeutics is a buy, Stifel says

Knight Therapeutics (Knight Therapeutics Stock Quote, Chart, News, Analysts, Financials TSXV:GUD) is continuing to build momentum, according to Stifel Nicolaus… [Read More]

3 days ago

Groupon wins price target raise at Roth

Roth Capital Partners has raised its price target on Groupon (Groupon Inc Stock Quote, Chart, News, Analysts, Financials NASDAQ:GRPN) to… [Read More]

3 days ago

Trulieve Cannabis is a buy, Beacon says

Trulieve Cannabis (Trulieve Cannabis Stock Quote, Chart, News, Analysts, Financials CSE:TRUL) delivered a strong start to fiscal 2025, beating high-end… [Read More]

3 days ago